ARTICLE | Clinical News
Foradil formoterol: Phase III
February 5, 2001 8:00 AM UTC
In a Phase III U.S. study in 541 patients with asthma, patients receiving 12 or 24 mg of Foradil twice daily experienced improvements in FEV1 for up to 12 hours after dosing compared to patients recei...